Literature DB >> 27725245

Estimation of the receptor-state affinity constants of ligands in functional studies using wild type and constitutively active mutant receptors: Implications for estimation of agonist bias.

Frederick J Ehlert1, Richard S L Stein2.   

Abstract

We describe a method for estimating the affinities of ligands for active and inactive states of a G protein-coupled receptor (GPCR). Our protocol involves measuring agonist-induced signaling responses of a wild type GPCR and a constitutively active mutant of it under control conditions and after partial receptor inactivation or reduced receptor expression. Our subsequent analysis is based on the assumption that the activating mutation increases receptor isomerization into the active state without affecting the affinities of ligands for receptor states. A means of confirming this assumption is provided. Global nonlinear regression analysis yields estimates of 1) the active (Kact) and inactive (Kinact) receptor-state affinity constants, 2) the isomerization constant of the unoccupied receptor (Kq-obs), and 3) the sensitivity constant of the signaling pathway (KE-obs). The latter two parameters define the output response of the receptor, and hence, their ratio (Kq-obs/KE) is a useful measure of system bias. If the cellular system is reasonably stable and the Kq-obs and KE-obs values of the signaling pathway are known, the Kact and Kinact values of additional agonists can be estimated in subsequent experiments on cells expressing the wild type receptor. We validated our method through computer simulation, an analytical proof, and analysis of previously published data. Our approach provides 1) a more meaningful analysis of structure-activity relationships, 2) a means of validating in silico docking experiments on active and inactive receptor structures and 3) an absolute, in contrast to relative, measure of agonist bias.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active state; Agonist bias; Constitutive activity; Efficacy; Inactive state; Monod-Wyman-Changeux model; Observed affinity; Receptor activation; Receptor state affinity constants; System bias

Mesh:

Substances:

Year:  2016        PMID: 27725245      PMCID: PMC5769967          DOI: 10.1016/j.vascn.2016.09.007

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  37 in total

Review 1.  Binding energy, specificity, and enzymic catalysis: the circe effect.

Authors:  W P Jencks
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1975

Review 2.  Receptor-associated proteins and synaptic plasticity.

Authors:  Emile G Bruneau; Jose A Esteban; Mohammed Akaaboune
Journal:  FASEB J       Date:  2008-10-31       Impact factor: 5.191

Review 3.  The gating isomerization of neuromuscular acetylcholine receptors.

Authors:  Anthony Auerbach
Journal:  J Physiol       Date:  2009-11-23       Impact factor: 5.182

4.  A simple method for quantifying functional selectivity and agonist bias.

Authors:  Terry Kenakin; Christian Watson; Vanessa Muniz-Medina; Arthur Christopoulos; Steven Novick
Journal:  ACS Chem Neurosci       Date:  2011-12-20       Impact factor: 4.418

Review 5.  Efficacy and ligand bias at the μ-opioid receptor.

Authors:  E Kelly
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  Estimation of relative microscopic affinity constants of agonists for the active state of the receptor in functional studies on M2 and M3 muscarinic receptors.

Authors:  John A Tran; Alexander Chang; Minoru Matsui; Frederick J Ehlert
Journal:  Mol Pharmacol       Date:  2008-11-07       Impact factor: 4.436

7.  The dynamic process of β(2)-adrenergic receptor activation.

Authors:  Rie Nygaard; Yaozhong Zou; Ron O Dror; Thomas J Mildorf; Daniel H Arlow; Aashish Manglik; Albert C Pan; Corey W Liu; Juan José Fung; Michael P Bokoch; Foon Sun Thian; Tong Sun Kobilka; David E Shaw; Luciano Mueller; R Scott Prosser; Brian K Kobilka
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

Review 8.  Therapeutic potential of β-arrestin- and G protein-biased agonists.

Authors:  Erin J Whalen; Sudarshan Rajagopal; Robert J Lefkowitz
Journal:  Trends Mol Med       Date:  2010-12-21       Impact factor: 11.951

9.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

10.  Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.

Authors:  Dean P Staus; Ryan T Strachan; Aashish Manglik; Biswaranjan Pani; Alem W Kahsai; Tae Hun Kim; Laura M Wingler; Seungkirl Ahn; Arnab Chatterjee; Ali Masoudi; Andrew C Kruse; Els Pardon; Jan Steyaert; William I Weis; R Scott Prosser; Brian K Kobilka; Tommaso Costa; Robert J Lefkowitz
Journal:  Nature       Date:  2016-07-13       Impact factor: 49.962

View more
  1 in total

1.  A single unified model for fitting simple to complex receptor response data.

Authors:  Peter Buchwald
Journal:  Sci Rep       Date:  2020-08-07       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.